A rapid computational method for lead evolution: Description and application to α1-adrenergic antagonists

Journal of Medicinal Chemistry

Volumn 43, Issue 14, 2000, Pages 2770-2774

  Bradley, Erin K ^a   Beroza, Paul ^a   Penzotti, Julie E ^a   Grootenhuis, Peter D J ^a   Spellmeyer, David C ^a   Miller, Jennifer L ^a  

^a Formerly CombiChem Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HALOPERIDOL; PRAZOSIN;

ARTICLE; DRUG ACTIVITY; DRUG CONFORMATION; DRUG RESEARCH; PHARMACOPHORE;

ADRENERGIC ALPHA-ANTAGONISTS; DATABASES, FACTUAL; DRUG DESIGN; GLYCINE; HETEROCYCLIC COMPOUNDS; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0034644135     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990578n     Document Type: Article

References (52)

1. Kennedy, T. Managing the drug discovery process. Drug Discovery Today 1997, 2, 436-444.
2. Kearsley, S. K.; Underwood, D. J.; Sheridan, R. P.; Miller, M. D. Flexibases: a way to enhance the use of molecular docking methods. J. Comput.-Aided Mol. Des. 1994, 8, 565-582.
3. Makino, S.; Ewing, T. J.; Kuntz, I. D. DREAM++: flexible docking program for virtual combinatorial libraries. J. Comput.-Aided Mol. Des. 1999, 13, 513-532.
4. Spellmeyer, D. C.; Grootenhuis, P. D. J. Recent Developments in Molecular Diversity: Computational Approaches to Combinatorial Chemistry. Annu. Rep. Med. Chem. Rev. 1999, 34, 287-296.
5. Zheng, W. F.; Cho, S. J.; Tropsha, A. Rational combinatorial library design. 1 Focus-2D: A new approach to the design of targeted combinatorial chemical libraries J. Chem. Inf. Comput. Sci. 1998, 38, 251-258.
6. Beavers, M. P. Discovery of a small molecule motilin antagonist through electronic database screening. Innovative Computational Applications, San Francisco, CA, Oct 25-26, 1999.
7. Bures, M. G. Recent Techniques and Applications in Pharmacophore Mapping. In Practical Application of Computer-Aided Design; Charifson, P. S., Ed.; Marcel-Dekker: New York, 1997; pp 39-72.
8. Van Drie, J. H. Strategies for the determination of pharmacophoric 3D database queries. J. Comput.-Aided Mol. Des. 1997, 11, 39.
9. Davies, K.; Briant, C. Combinatorial chemistry library design using pharmacophore diversity. Net. Sci. 1996, 1, http://www.netsci.org/Science/Combichem/feature05.html.
10. Pickett, S. D.; Mason, J. S.; McLay, I. M. Diversity profiling and design using 3D pharmacophores: Pharmacophore-derived queries (PDQ). J. Chem. Inf. Comput. Sci. 1996, 36, 1214-1223.
11. Finn, P. W.; Mason, J. S. Computer-based screening of compound databases for the identification of new leads. Drug Discovery Today 1996, 1, 363-370.
12. Ashton, M. J.; Jaye, M. C.; Mason, J. S. New perspectives in lead generation II: Evaluating molecular diversity. Drug Discovery Today 1996, 1, 71-78.
13. Van Drie, J. H. An inequality for 3D database searching and its use in evaluating the treatment of conformational flexibility Comput.-Aided Mol. Des. 1996, 10, 623.
14. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; L. T., B.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Viitanen, S. Rational design of potent, bioavailable, nonpeptide cyclic ureeas as HIV protease inhibitors. Science 1994, 263, 380-384.
15. Martin, Y. C. 3D database searching in drug design. J. Med. Chem. 1992, 35, 2145-2154.
16. Mason, J. S.; Cheney, D. L. Ligand-Receptor 3-D similarity studies using multiple 4-point pharmacophores. Pacific Symposium on Biocomputing '99, Mauna Lani, HI, Jan 1999.
17. Miller, M. D.; Sheridan, R. P.; Kearsley, S. K. SQ: A program for rapidly producing pharmacophorically relevant molecular superpositions. J. Med. Chem. 1999, 42, 1505-1514.
18. Myers, P. L.; Greene, J. W.; Saunders, J.; Teig, S. L. Rapid, reliable drug discovery. Today's Chemist at Work 1997, 6, 46-53.
19. Teig, S. L. Informative libraries are more useful than diverse ones. J. Biomol. Screening 1998, 3, 85-88.
20. McGregor, M. J.; Muskal, S. M. Pharmacophore Fingerprinting. 1. Application to QSAR and focused library design. J. Chem. Inf. Comput. Sci. 1999, 39, 569-574.
21. Bersuker, I. B.; Bahceci, S.; Boggs, J. E.; Pearlman, R. S. An electron-conformational method of identification of pharmacophore and anti-pharmacophore shielding: application to rice blast activity. J. Comput.-Aided Mol. Des. 1999, 13, 419-434.
22. Zuckermann, R. N.; Martin, E. J.; Spellmeyer, D. C.; Stauber, G. B.; Shoemaker, K. R.; Kerr, J. M.; Figliozzi, G. M.; Goff, D. A.; Siani, M. A.; Simon, R. J.; Banville, S. C.; Brown, E. G.; Wang, L.; Richter, L. S.; Moos, W. H. Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. J. Med. Chem. 1994, 37, 2678-2685.
23. Van Drie, J. H.; Nugent, R. A. Addressing the challenges of combinatorial chemistry: 3D databases, pharmacophore recognition and beyond. SAR QSAR Environ. Res. 1998, 9, 1-21.
24. Mason, J. S.; Morize, I.; Menard, I. R.; Cheney, D. L.; Hulme, C.; Labaudiniere, R. F. New 4-point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J. Med. Chem. 1999, 42, 3251-3264.
25. Greene, J.; Kahn, S.; Savoj, H.; Sprague, P.; Teig, S. Chemical Functional Queries for 3D Database Search. J. Chem. Inf. Comput. Sci. 1994, 34, 1297-1308.
26. Teig, S. L.; Smellie, A. S.; CombiChem, I. Method and Apparatus for conformationally analyzing molecular fragments. W09859306, 1998.
27. Smellie, A.; Teig, S. Conformational analysis by intersection: Ring conformations. 217th National Meeting of the American Chemical Society, Anaheim, CA, Mar 21-26, 1999.
28. Smellie, A.; Teig, S. L. Manuscript in preparation.
29. Barnum, D.; Greene, J.; Smellie, A.; Sprague, P. Identification of Common Functional Configurations Among Molecules. J. Chem. Inf. Comput. Sci. 1996, 36, 563-571.
30. Stanton, R. V.; Eksterowicz, J. Personal communication.
31. Mottram, D. R.; Kapur, H. The α-adrenoceptor blocking effects of a new benzodioxane. J. Pharm. Pharmacol. 1975, 27, 295-296.
32. Eltze, M. Investigations on the mode of action of a new antihypertensive drug, urapidil, in the isolated rat vas deferens. Eur. J. Pharmacol. 1979, 59, 1-9.
33. Engel, G.; Hoyer, D. [125I]BE 2254, a new high affinity radio-ligand for alpha 1-adrenoceptors. Eur. J. Pharmacol. 1981, 73, 221-224.
34. Remy, D. C.; Britcher, S. F.; King, S. W.; Anderson, P. S.; Hunt, C. A.; Randall, W. C.; Belanger, P.; Atkinson, J. G.; Girard, Y.; Rooney, S.; Fuentes, J. J.; Totaro, J. A.; Robinson, J. L.; Risley, E. A.; Williams, M. Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives. J. Med. Chem. 1983, 26, 974-980.
35. 1-adrenoreceptor antagonist 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]methyl]-1,4-benzoxathian (benoxathian). Eur. J. Med. Chem. 1987, 22, 23-26.
36. 1-adrenoreceptor blocking activity. J. Med. Chem. 1988, 31, 2300-2304.
37. 1-adrenoreceptor antagonists. J. Med. Chem. 1990, 33, 2946-2948.
38. 1 adrenoceptor ligands. J. Med. Chem. 1991, 34, 1850-1854.
39. Giardina, D.; Gulini, U.; Massi, M.; Piloni, M. G.; Pompei, P.; Rafaiani, G.; Melchiorre, C. Structure-activity relationships in prazosin-related compounds. 2. Role of the piperazine ring on a-blocking activity. J. Med. Chem. 1993, 36, 6.
40. Ruffolo, R. R., Jr.; Bondinelli, W.; Hieble, J. P. α-and β-Adreno-receptors: From gene to clinic. 2. Structure-activity relationships and therapeutic applications. J. Med. Chem. 1995, 38, 3681-3716.
41. Timmermans, P. B. W. M.; Chiu, A. T.; Thoolen, M. J. M. C. Alpha-adrenergic receptors. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: Oxford, 1990; Vol. 3, pp 133-185.
42. 1 receptors. A comparison of CoMFA models. J. Med. Chem. 1997, 40, 1648-1656.
43. 1-adrenoceptor selective antagonists: Synthesis, modeling, and binding studies. Bioorg. Med. Chem. 1998, 6, 925-935.
44. 1 receptors. J. Med. Chem. 1998, 41, 1997-2009.
45. Tagmatarchis, N.; Thermos, K.; Katerinopoulos, H. E. N-(Iodopropenyl)-octahydrobenzo[f]-and -[g]quinolines: Synthesis and adrenergic and dopaminergic activity studies. J. Med. Chem. 1998, 41, 4165-4170.
46. Barlocco, D.; Cignarella, G.; Montesano, F.; Leonardi, A.; Mella, M.; Toma, L. Novel adrenoceptor antagonists with a tricylcic pyrrolodipyridazine skeleton. J. Med. Chem. 1999, 42, 2.
47. Stanton, R. V.; Mount, J.; Miller, J. L. Combinatorial Library Design: Maximizing Model-Fitting Compounds within Matrix Synthesis Constraints. J. Chem. Inf. Comput. Sci. 2000, 40, 701-705.
48. Daylight Chemical Information Systems, www.daylight.com, Santa Fe, NM, 1995.
49. 1 is [N-[2-(4-hydroxyphenyl)ethyl]glycyl][N-(4-biphenylyl)glycyl]-N-(2-phenylethyl) glycinamide.
50. 2 is [N-[2-(4-hydroxyphenyl)ethyl]glycyl][N-(4-phenoxyphenyl)-glycyl]-N-(2- phenylethyl)glycinamide.
51. 3 is [N-[2-(4-hydroxyphenyl)ethyl]glycyl][N-(4-biphenylyl)glycyl]-N-(2-biphenyl) glycinamide.
52. 4 is 2-[[[2-(2,6-dimethoxyphenoxyl)ethyl]amino]methyl]-1,4-benzodioxan.